Single-Use Systems
Single-use systems (SUS) — disposable bags, tubing, connectors, filters and assemblies replacing stainless-steel process equipment — are now standard in biomanufacturing because they eliminate cleaning and cleaning-validation between batches and speed changeover. But they shift the risk profile: the polymer contact surfaces can leach chemicals into the product, integrity depends on the component and its assembly rather than a validated CIP/SIP cycle, and the manufacturer inherits a deep supply-chain dependency on the component maker. Controlling those three risks is what SUS qualification is about.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 21 LINKSSingle-use systems remove cleaning validation but reshape GMP risk into three: extractables/leachables, fluid-path integrity, and deep supplier dependence — judged against your process, not the supplier datasheet, and recorded below.
06 · QUALITY MATURITY — SINGLE-USE SYSTEMS, REACTIVE TO ADAPTIVE
Disposables are adopted for convenience; extractables/leachables are unassessed and the supplier is qualified on paper only.
Supplier extractables data is on file, but a product-specific leachables assessment for the real contact conditions is missing.
Leachables are assessed against the actual process and toxicological limits; integrity and assembly are controlled and the supplier holds a change agreement.
Component and incoming-inspection data are trended; a silent formulation or sterilization change is caught through change notification before it reaches product.
SUS risk drives assembly design and second-source strategy; supplier sterilization and E&L evidence are integral to the sterility-assurance case.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 3
Derived from the 3 standards SPEQ maps to this subject, across 3 regulatory bodies: EMA, ICH, USP.
RECORDS & OBJECTIVE EVIDENCE
- A product-specific leachables assessment for real contact conditions vs. toxicological limits
- Supplier extractables characterisation and sterilization validation on file
- Supplier qualification with a binding change-notification agreement
- Incoming-component controls and point-of-use integrity checks
- A documented second-source strategy for critical disposable assemblies
COMMON INSPECTION FINDINGS
- Reliance on supplier extractables data with no product-specific leachables assessment
- Sterility claimed from supplier validation with no supplier change control
- Integrity risks (pinholes, connector leaks, mis-assembly) uncontrolled at point of use
- Film or component formulation changed by the supplier without notification
- Single-source critical assembly with no continuity or requalification plan
What single-use changes
Replacing fixed stainless equipment with disposable assemblies removes the cleaning and cleaning-validation burden and the associated cross-contamination risk, which is a genuine quality and efficiency gain, especially for multiproduct facilities. It also enables faster campaign turnaround and lower capital cost. But the risk does not disappear; it changes shape — sterility and integrity now rest on the incoming component and its correct installation rather than on a validated in-place cleaning and sterilization cycle.
Because the plastic is discarded after one use, there is no equipment cleaning record to point to; instead there is a component-qualification and supplier-control record. EU GMP Annex 1 addresses single-use systems directly, expecting the same assurance of sterility and integrity for a disposable fluid path as for a fixed one, and requiring the specific risks of SUS to be assessed.
Extractables and leachables
The defining SUS risk is chemical: polymer films, tubing, additives, plasticizers and adhesives can release compounds into the process fluid. Extractables are what can be forced out under exaggerated conditions; leachables are what actually migrate into the product under real process conditions. Because SUS often contact the product for extended times at process temperatures — and some steps concentrate the product — the leachables burden can be material and must be assessed against toxicological limits.
A defensible program uses supplier extractables data as a starting point and then performs a product-specific leachables assessment for the actual contact conditions (fluid, time, temperature, surface-area-to-volume ratio), with analytical methods per the analytical-method lifecycle. SPEQ synthesis: supplier extractables data is necessary but not sufficient — it is generated under the supplier's model solvents and conditions, not your product's, so the leachables risk must be judged against your process, not delegated to the datasheet.
Integrity and sterility assurance
A single-use fluid path is only sterile if the component is integral and correctly connected. SUS are typically supplied pre-sterilized (commonly by gamma irradiation), so the manufacturer relies on the supplier's sterilization validation and must control that relationship. Integrity risks include film pinholes, tubing failures, connector leaks and mis-assembly, and these can be introduced in manufacture, shipping, storage or installation — so point-of-use inspection and, where feasible, integrity testing of the assembly become important controls.
Annex 1 expects the risks of the single-use assembly — including the installation and connection steps and the potential for damage — to be assessed and controlled, and it recognizes that aseptic connection technology and the assembly design are part of the sterility-assurance case. Pre-use and post-use integrity considerations for single-use filters apply here as they do for fixed filters.
Supplier qualification and supply security
Because the disposable component is a sterile, product-contact critical item that the manufacturer cannot re-make, SUS create a deep dependency on the supplier: sterilization validation, extractables characterization, change notification, and consistent component quality all sit upstream. Supplier qualification therefore has to be rigorous, with a change-control agreement so the supplier cannot silently alter a film formulation or a component that would invalidate the leachables assessment or the sterilization claim.
Supply security is the second dimension — single-source disposable assemblies are a business-continuity risk, and requalifying a second source means repeating extractables/leachables and integrity work. The practical control set is a strong supplier-qualification program, contractual change notification, incoming-component controls, and a documented second-source strategy where the component is critical.
FREQUENTLY ASKED
Do single-use systems eliminate validation work?
They eliminate cleaning and cleaning-validation between batches, but they add extractables/leachables assessment, integrity assurance, and rigorous supplier qualification (including reliance on the supplier's sterilization validation). The validation burden shifts rather than disappears, and EU GMP Annex 1 expects the specific SUS risks to be assessed and controlled.
Is supplier extractables data enough for leachables safety?
No. Supplier extractables data is generated under model solvents and exaggerated conditions and is a starting point, not a conclusion. Leachables must be assessed for the actual product, contact time, temperature and surface-area-to-volume ratio, then compared against toxicological limits. The risk is judged against your process, not the datasheet.
How is sterility assured for a disposable fluid path?
Single-use assemblies are typically supplied pre-sterilized (often by gamma irradiation), so sterility rests on the supplier's validated sterilization plus the component's integrity and correct aseptic connection at point of use. Integrity risks (pinholes, connector leaks, mis-assembly) must be controlled through inspection, aseptic connection technology and, where feasible, integrity testing.